BioSpace News Archive

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the publication of secondary efficacy and patient-reported outcomes from its Phase 2b randomized clinical trial of tapinarof cream for the treatment of atopic dermatitis in The Journal of the American Academy of Dermatology

Expansion enables full commercial scale plasmid DNA manufacturing capabilities Manufacturing program supports upcoming clinical trials, including Oncoprex in combination with Tagrisso®, which received FDA Fast Track Designation AUSTIN, Texas--( BUSINESS WIRE )-- Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and dia

The Montreal Heart Institute (MHI) and Thermedical ® , a developer of thermal-ablation systems to treat ventricular arrhythmias, today announced the first ablation performed using the groundbreaking Durablate® retractable needle catheter and degassed saline, which together eliminate over 98% of the air bubbles that can lead to stroke. Health Canada and the U.S. Food & Drug Administration (FDA) approved Thermedical’s

Perrigo Company plc, a leading global provider of Quality, Affordable Self-Care Products, announced that Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo, commenced a registered public offering of senior notes.

Walgreens, who has made major strides in recent years to improve product mix with natural alternatives, is once again leading the retailer pack with the introduction of EMUAIDMAX First Aid Ointment

KORE , the independent global IoT leader, today announced an ongoing partnership with Dexcom, Inc., the world leader in continuous glucose monitoring (CGM), to rapidly deliver an innovative remote patient monitoring solution to assist care providers during the COVID-19 global pandemic.

WEG232 is a topical treatment with specific substance P-receptor inhibitor for Erlotinib-induced facial dermatitis and hair loss in cancer patients [16-June-2020] NEW YORK , June 16, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announced that it has expanded its sponsored research agreement with the George Washington U

OliX Pharmaceuticals, Inc. announced that the Company signed an exclusive contract with LGC Biosearch Technologies Inc., a contract development and manufacturing organization and part of the global life sciences tools company headquartered in London, to scale production of OliX’s OLX301D therapeutic candidate.

Today Proximo Medical , LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with Coala Life , a leading Swedish-headquartered digital health company, in select U.S.

ISOThrive Inc., a microbiome therapeutics company announced today that the U.S. Patent and Trademark Office has issued a Composition of Matter patent for its proprietary microbiome therapeutic Maltosyl-Isomaltooligosaccharide (MIMO™). The company has c